Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy

Purpose: Local breast cancer relapse after breast-saving surgery and radiotherapy is associated with increased risk of distant metastasis formation. The mechanisms involved remain largely elusive. We used the well-characterized 4T1 syngeneic, orthotopic breast cancer model to identify novel mechanisms of postradiation metastasis. Experimental Design: 4T1 cells were injected in 20 Gy preirradiated mammary tissue to mimic postradiation relapses, or in nonirradiated mammary tissue, as control, of immunocompetent BALB/c mice. Molecular, biochemical, cellular, histologic analyses, adoptive cell transfer, genetic, and pharmacologic interventions were carried out. Results: Tumors growing in preirradiated mammary tissue had reduced angiogenesis and were more hypoxic, invasive, and metastatic to lung and lymph nodes compared with control tumors. Increased metastasis involved the mobilization of CD11b+c-Kit+Ly6GhighLy6Clow(Gr1+) myeloid cells through the HIF1-dependent expression of Kit ligand (KitL) by hypoxic tumor cells. KitL-mobilized myeloid cells homed to primary tumors and premetastatic lungs, to give rise to CD11b+c-Kit− cells. Pharmacologic inhibition of HIF1, silencing of KitL expression in tumor cells, and inhibition of c-Kit with an anti-c-Kit–blocking antibody or with a tyrosine kinase inhibitor prevented the mobilization of CD11b+c-Kit+ cells and attenuated metastasis. C-Kit inhibition was also effective in reducing mobilization of CD11b+c-Kit+ cells and inhibiting lung metastasis after irradiation of established tumors. Conclusions: Our work defines KitL/c-Kit as a previously unidentified axis critically involved in promoting metastasis of 4T1 tumors growing in preirradiated mammary tissue. Pharmacologic inhibition of this axis represents a potential therapeutic strategy to prevent metastasis in breast cancer patients with local relapses after radiotherapy. Clin Cancer Res; 18(16); 4365–74. ©2012 AACR.

[1]  R. Spiro,et al.  Failure in the neck following multimodality treatment for advanced head and neck cancer. , 1984, Head & neck surgery.

[2]  R. Camplejohn,et al.  The tumour bed effect: a cell kinetic and histological investigation of tumours growing in irradiated mouse skin. , 1985, The British journal of radiology.

[3]  V. Courtenay,et al.  Tumour bed effect: hypoxic fraction of tumours growing in preirradiated beds. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[4]  L J Peters,et al.  Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas. , 1988, Cancer research.

[5]  C. Croce,et al.  Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[6]  P. Besmer.  The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. , 1991, Current opinion in cell biology.

[7]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[8]  E. Huang,et al.  The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. , 1993, Development (Cambridge, England). Supplement.

[9]  M. Barton.  Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula. , 1995, International journal of radiation oncology, biology, physics.

[10]  C. Redmond,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, New England Journal of Medicine.

[11]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[12]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[13]  V. Broudy,et al.  Stem cell factor and hematopoiesis. , 1997, Blood.

[14]  Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome , 1998 .

[15]  D. Hanahan,et al.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.

[16]  S Torihashi,et al.  Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype. , 1999, Gastroenterology.

[17]  Ronin,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, The New England journal of medicine.

[18]  A. Harris,et al.  Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas , 2000, The Journal of pathology.

[19]  F. Vicini,et al.  Does local recurrence affect the rate of distant metastases and survival in patients with early‐stage breast carcinoma treated with breast‐conserving therapy? , 2003, Cancer.

[20]  F. Mascarelli,et al.  Roles of Stem Cell Factor/c-Kit and Effects of Glivec®/STI571 in Human Uveal Melanoma Cell Tumorigenesis* , 2004, Journal of Biological Chemistry.

[21]  K. Welte,et al.  Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines , 2004, Acta Neuropathologica.

[22]  E. Musulen,et al.  Gastrointestinal stromal tumors , 2006, Abdominal Imaging.

[23]  E. Rofstad,et al.  Increased Metastatic Dissemination in Human Melanoma Xenografts after Subcurative Radiation Treatment , 2004, Cancer Research.

[24]  E. Rofstad,et al.  The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. , 2005, Cancer research.

[25]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[26]  P. Workman,et al.  Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. , 2005, Cancer research.

[27]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[28]  D. Printz,et al.  Detection of differentiation‐ and activation‐linked cell surface antigens on cultured mast cell progenitors , 2005, Allergy.

[29]  Naz Chaudary,et al.  Hypoxia and metastasis in breast cancer. , 2006, Breast disease.

[30]  L. Rönnstrand,et al.  The stem cell factor receptor/c-Kit as a drug target in cancer. , 2006, Current cancer drug targets.

[31]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[32]  R. Schwendener,et al.  Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach , 2006, British Journal of Cancer.

[33]  P. Sinha,et al.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. , 2007, Cancer research.

[34]  P. Focia,et al.  Structural basis for stem cell factor–KIT signaling and activation of class III receptor tyrosine kinases , 2007, The EMBO journal.

[35]  M. Giacca,et al.  Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels , 2007, Cell.

[36]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[37]  S. Vandenberg,et al.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.

[38]  R. Mirimanoff,et al.  CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. , 2008, Cancer research.

[39]  D. Carbone,et al.  Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.

[40]  H. Xiong,et al.  SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. , 2008, Blood.

[41]  E. Crivellato,et al.  Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. , 2008, Cancer letters.

[42]  V. Bronte,et al.  Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.

[43]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[44]  G. Christofori,et al.  Myeloid Cells Contribute to Tumor Lymphangiogenesis , 2009, PloS one.

[45]  H. Joensuu,et al.  Tumour microvessel endothelial cell KIT and stem cell factor expression in human solid tumours , 2009, Histopathology.

[46]  V. Sondak,et al.  c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. , 2009, Histology and histopathology.

[47]  J. Mestan,et al.  Extended kinase profile and properties of the protein kinase inhibitor nilotinib. , 2010, Biochimica et biophysica acta.

[48]  Julien Laurent,et al.  Fc block treatment, dead cells exclusion, and cell aggregates discrimination concur to prevent phenotypical artifacts in the analysis of subpopulations of tumor‐infiltrating CD11b+ myelomonocytic cells , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[49]  R. Mirimanoff,et al.  Radiotherapy Suppresses Angiogenesis in Mice through TGF-βRI/ALK5-Dependent Inhibition of Endothelial Cell Sprouting , 2010, PloS one.

[50]  C. Liao,et al.  Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment , 2010, Proceedings of the National Academy of Sciences.

[51]  H. Vogel,et al.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. , 2010, The Journal of clinical investigation.

[52]  M. Colombo,et al.  Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors , 2011, Oncogene.

[53]  J. Talmadge,et al.  Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells. , 2011, International immunopharmacology.